Market Cap : 2.71 B | Enterprise Value : 3.59 B | PE Ratio : At Loss | PB Ratio : 3.27 |
---|
NAS:NUVA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NUVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NuVasive has the Profitability Rank of 6.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %NuVasive's Operating Margin % for the quarter that ended in Jun. 2022 was 8.20%. As of today, NuVasive's Piotroski F-Score is 5.
For the Medical Devices subindustry, NuVasive's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, NuVasive's Profitability Rank distribution charts can be found below:
* The bar in red indicates where NuVasive's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
NuVasive has the Profitability Rank of 6.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
NuVasive's Operating Margin % for the quarter that ended in Jun. 2022 is calculated as:
Operating Margin % | = | Operating Income (Q: Jun. 2022 ) | / | Revenue (Q: Jun. 2022 ) |
= | 25.447 | / | 310.451 | |
= | 8.20 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
NuVasive has an F-score of 5 indicating the company's financial situation is typical for a stable company.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
Warning Sign:
NuVasive Inc operating margin has been in a 5-year decline. The average rate of decline per year is -16.2%.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of NuVasive's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Rosenbaum Marc W. | officer: Chief Accounting Officer | 7475 LUSK BLVD. SAN DIEGO CA 92121 |
Morton Andrew C. | officer: SVP, CHRO | 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 |
Raimundo Amy Belt | director | ONE KAISER PLAZA, 22ND FLOOR OAKLAND CA 94612 |
Kadia Siddhartha | director | 7475 LUSK BOULEVARD SAN DIEGO CA 92121 |
Calafiore Massimo | officer: EVP, Global Business Units | 7475 LUSK BLVD. SAN DIEGO CA 92121 |
Boucher Brent J. | officer: EVP, Global Commercial | 14 PLAZA DRIVE LATHAM NY 12110 |
Harbaugh Matthew K | officer: EVP and CFO | 675 MCDONNELL BLVD. HAZELWOOD MO 63042 |
Wolf Dale A. | officer: SVP, Global Operations | 7475 LUSK BLVD. SAN DIEGO CA 92121 |
Vitale Lucas | officer: Chief Human Resources Officer | 7475 LUSK BLVD SAN DIEGO CA 92121 |
Mcclintock Paul | officer: President, U.S. Commercial | 7475 LUSK BLVD SAN DIEGO CA 92121 |
Barry James Christopher | director, officer: Chief Executive Officer | 7475 LUSK BLVD SAN DIEGO CA 92121 |
Huennekens R Scott | director | C/O VOLCANO CORPORATION 11455 EL CAMINO REAL, SUITE 460 SAN DIEGO CA 92130 |
Sisitsky Nathaniel | officer: SVP & General Counsel | C/O CAREFUSION CORPORATION 3750 TORREY VIEW COURT SAN DIEGO CA 92130 |
Deford John A | director | C R BARD INC 730 CENTRAL AVENUE MURRAY HILL NJ 07974 |
Asarpota Rajesh | officer: CFO | 1300 N. KELLOGG DRIVE SUITE D ANAHEIM CA 92807 |
Other Sources
By Zacks 2021-07-29
By Zacks 2021-07-21
By Seekingalpha 2021-07-28
By Zacks 2021-11-09
By Seekingalpha 2022-02-23
By Zacks 2021-09-06
By Zacks 2021-06-04
By Zacks 2021-07-13
By Seekingalpha 2021-11-09
By Zacks 2022-03-29
By Zacks 2021-05-06
By Zacks 2021-09-23
By Zacks 2022-01-10
By Zacks 2021-08-27
By Zacks 2021-11-10